通过TET2介导的KMT2D自我转录的缺陷在肝细胞癌中赋予了可向的脆弱性
Yuting Jin1, Keqiang Rao1, Jiaojiao Zheng2
1Department of Liver Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200120, China.
DNA二氧化酶TET2和基因素甲基转移酶KMT2D在肝细胞癌 (HCC) 中合作. 这种TET2-KMT2D轴对瘤抑制至关重要,并为HCC治疗提供了一个新的治疗点.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 肝细胞癌 (HCC) 是全球癌症死亡的主要原因.
- 现有的HCC疗法往往会导致不良反应和疾病复发,突出显示需要新的治疗策略.
研究的目的:
- 调查TET2和KMT2D在HCC发病过程中的协作作用.
- 阐明在HCC.中TET2-KMT2D相互作用背后的分子机制.
- 探索针对HCC中TET2-KMT2D轴的治疗潜力.
主要方法:
- RNA测序 (RNA-seq) 用于识别TET2.2的表观遗传标.
- 分析KMT2D在自我转录和与TET2.2相互作用中的作用.
- 实体研究评估KMT2D枯竭对瘤生长和对维生素C和西斯等疗法的反应的影响.
主要成果:
- TET2和KMT2D合作调节KMT2D和ARID1A在HCC中的转录.
- KMT2D充当瘤抑制剂,调解维生素C的抗瘤作用,并使HCC对西斯普拉丁敏感.
- TET2-KMT2D轴是HCC患者的显著预后生物标志物,较高水平与更好的结果相关.
结论:
- 确定了TET2-KMT2D交叉对话在调节KMT2D自我转录中的新机制.
- TET2-KMT2D轴代表了肝细胞癌的一个有前途的治疗点.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
10:49A Murine Cell Line Based Model of Chronic CDK9 Inhibition to Study Widespread Non-Genetic Transcriptional Elongation Defects TEdeff in Cancers
Published on: September 26, 2019
相关概念视频
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Master Transcription Regulators
Abnormal Proliferation
Non-LTR Retrotransposons
General Transcription Factors
lncRNA - Long Non-coding RNAs
